RxDoctor Payments DataLook up a doctor →

Shveta Gupta

Pediatric Hematology-Oncology · Orlando, FLNPI 1366881468

Payments from drug & device makers

$822,348in general payments, 2019–2025

Across 696 payments — averaging $1181.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$371K
  • Sanofi$242K
  • Bayer$72K
  • CSL Behring$26K
  • Pfizer$25K
  • Novo Nordisk AS$21K
  • plus $65K from 13 others
$17,205in research payments, 2019–2025

Across 7 payments — averaging $2457.87 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Bayer$8K
  • Octapharma USA, Inc.$5K
  • F. Hoffmann-la Roche AG$4K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$822,348 in reported general payments places this provider in the 95th percentile of 132 pediatric hematology-oncology providers in Florida.

See all pediatric hematology-oncology providers in Florida

Other pediatric hematology-oncology in Orlando

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →